DTU Nutech, Center for Nuclear Technologies
Early, efficient and cost effective detection and treatment
of bladder cancer
What do we offer?
New technology allowing surgeons to perform detection of
non-muscle invasive (NMI) tumours in the bladder, using
photodynamic diagnosis, in an outpatient department
(OPD) and subsequent surgical removal of the tumours by
laser assisted devascularisation without the patient being
anaesthetised. In summary, 2-3 days of hospitalisation can
be reduced to a 2-hour procedure in an outpatient setting.
Novel light source for use with commercially available
cystoscopes has been tested clinically in patients using
photodynamic diagnostics (PDD) as prescribed in the
European guidelines for TUR-B. Further clinical trials in
outpatient department and OR required to validate noinferiority
of the novel procedure.
Laser treatment of non-muscular invasive (NMI) bladder
tumours has successfully been tested in outpatient
department. The laser-based method is currently being
validated in a phase III study at the Urology department of
What differentiates us?
This turn-key project uses a novel light source for fluorescence assisted cystoscopy readily compatible with existing
cystoscope equipment for detection of bladder tumours. A commercially available fibre coupled laser system has
been integrated with conventional cystoscopes for subsequent treatment of NMI tumours in the bladder.
What do we look for at the Medico Bazar?
Potential medical partners for clinical tests of light source and funding agencies
DTU Center for Nuclear Technologies (NUTECH)
Lars R. Lindvold
+45 4677 4969